Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Kidney Int. 2019 Nov 28;97(5):966–979. doi: 10.1016/j.kint.2019.11.013

Figure 7. IL-6 mediates NGAL production by 1 hour in hepatocytes, in vitro.

Figure 7.

Vehicle (Veh) or 50 ng/mL of human recombinant IL-6 was added to human (HepG2) hepatocytes. (A) NGAL mRNA was increased in hepatocytes at 1, 2, and 4 hours after IL-6 addition. (B) NGAL protein levels in the media increased at 2 and 4, hours after IL-6 addition **P < 0.01 and ***P < 0.001 vs vehicle treated at the same time point by t test. n=2-5 for each condition.